FDA Adverse Event
Injury
Summary report: N
FINELINE II
MDR report key: 1852755
·
Received October 4, 2010
Report
- Report Number
- 2124215-2010-14759
- Event Type
- Injury
- Date Received
- October 4, 2010
- Date of Event
- July 15, 2010
- Report Date
- July 15, 2010
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- PMA / PMN Number
- P960004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
Additional Manufacturer Narrative · 1
THIS LEAD REMAINS IN SERVICE. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT EXPERIENCED CARDIAC TAMPONADE THE NIGHT AFTER IMPLANT. THE FIELD REPRESENTATIVE NOTED THAT WHEN DOING THE POST IMPLANT CHECK THE RIGHT VENTRICULAR (RV) LEAD IMPEDANCE MEASUREMENTS POST RV LEAD REPOSITIONING WENT FROM 730 OHMS TO 490 OHMS. TO DATE, NO FURTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FINELINE II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4470 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 75 YR | Life Threatening| R | 4469| 4470| S603 |